Technical Data
ANTXR1, phosphorylated (Tyr382) (Anthrax Toxin Receptor 1, Tumor Endothelial Marker 8, ATR, TEM8)
ANTXR1 is a type I transmembrane protein and is a tumor-specific endothelial marker that has been implicated in colorectal cancer. This protein has been shown to also be a docking protein or receptor for Bacillus anthracis toxin, the causative agent of the disease, anthrax. The binding of the protective antigen (PA) component, of the tripartite anthrax toxin, to this receptor protein mediates delivery of toxin components to the cytosol of cells. Once inside the cell, the other two components of anthrax toxin, edema factor (EF) and lethal factor (LF) disrupt normal cellular processes.

Suitable for use in ELISA and Dot Blot. Other applications not tested.

Recommended Dilution:
ELISA: 1:1,000
Dot Blot: 1:500
Optimal dilutions to be determined by the researcher.

Storage and Stability:
May be stored at 4C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20C. Aliquots are stable for at least 12 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
PabIgGAffinity Purified
200ul-20CBlue IceHumanRabbit
As reported
Synthetic phosphopeptide corresponding to amino acid residues surrounding Tyr382 of human ANTXR1 (KLH).
Purified by Protein A affinity chromatography.
Supplied as a liquid in PBS, 0.09% sodium azide.
Recognizes human ANTXR1 when phosphorylated at Tyr382.
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.
1.Werner,E., J. Biol. Chem. 281(32), 23227-23236 (2006). 2.Wei,W., Cell 124(6), 1141-1154 (2006). 3.Rainey,G.J., Proc. Natl. Acad. Sci. USA 102(37), 13278-13283 (2005).